Feedback wanted on new recommendations for managing atopic dermatitis | aad.org

Feedback wanted on new recommendations for managing atopic dermatitis

               

By Lawrence F. Eichenfield, MD

All dermatologists have experience treating atopic dermatitis (AD) patients. AD is one of the most common conditions we see in our offices, but at times one of the most challenging. Insights in to AD pathogenesis and evolving therapies have changed my practice greatly over time.

For the last two years, I’ve had the pleasure of co-chairing an Academy workgroup charged with updating our previous clinical guidelines of care on AD. These guidelines were last published in 2004, and since that time, a great deal of research has been published on AD. Together with my co-chair, Robert Sidbury, MD, and a stellar group of colleagues, we have thoroughly analyzed the new data to develop updated and expanded recommendations for the diagnosis, assessment, and treatment of AD. When complete, the Academy will have a four-part guideline series for this chronic and often debilitating condition.

The workgroup has done a fantastic job sifting through a large amount of information and putting it into a document we think will be helpful for you in your practice, and now we want your feedback. For the next 10 business days (June 7-June 20), part one of this guideline series will be available for review from the Academy website. This first section provides recommendations for diagnostic criteria, the use of biomarkers, disease and outcomes scales in the clinical setting, and awareness of common clinical associations that affect patients with AD. We value your thoughtful input to the document, as ultimately it’s a resource for all of us to ensure we are providing the best care to our AD patients.

If you would like to comment on the guideline, you will need to follow three steps:

  1. Be sure you have a current conflict of interest disclosure statement on record with the Academy.
  2. Review the draft guideline (the review period is now closed).
  3. Send all your comments via email to guidelines@aad.org.

We look forward to hearing from you.

Dr. Eichenfield is Chief of Pediatric and Adolescent Dermatology at Rady Children's Hospital, San Diego and at the University of California, San Diego School of Medicine and Professor of Clinical Pediatrics and Medicine (Dermatology) at the University.

Related resources:

Member Directory

ZIP code:
Radius:
Search